Proton beam radiation therapy for vestibular schwannomas-tumor control and hearing preservation rates: a systematic review and meta-analysis.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
04 Jul 2023
Historique:
received: 26 04 2023
accepted: 19 06 2023
revised: 12 06 2023
medline: 6 7 2023
pubmed: 5 7 2023
entrez: 4 7 2023
Statut: epublish

Résumé

Proton beam therapy is considered, by some authors, as having the advantage of delivering dose distributions more conformal to target compared with stereotactic radiosurgery (SRS). Here, we performed a systematic review and meta-analysis of proton beam for VSs, evaluating tumor control and cranial nerve preservation rates, particularly with regard to facial and hearing preservation. We reviewed, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) articles published between 1968 and September 30, 2022. We retained 8 studies reporting 587 patients. Overall rate of tumor control (both stability and decrease in volume) was 95.4% (range 93.5-97.2%, p heterogeneity= 0.77, p<0.001). Overall rate of tumor progression was 4.6% (range 2.8-6.5%, p heterogeneity < 0.77, p<0.001). Overall rate of trigeminal nerve preservation (absence of numbness) was 95.6% (range 93.5-97.7%, I Proton beam therapy for VSs achieves high tumor control rates, as high as 95.4%. Facial rate preservation overall rates are 93%, which is lower compared to the most SRS series. Compared with most currently reported SRS techniques, proton beam radiation therapy for VSs does not offer an advantage for facial and hearing preservation compared to most of the currently reported SRS series.

Identifiants

pubmed: 37402894
doi: 10.1007/s10143-023-02060-x
pii: 10.1007/s10143-023-02060-x
pmc: PMC10319703
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

163

Informations de copyright

© 2023. The Author(s).

Références

J Radiol Prot. 2016 Dec;36(4):785-818
pubmed: 27655064
Neurosurgery. 2005 Jul;57(1):60-70; discussion 60-70
pubmed: 15987541
J Neurol Surg B Skull Base. 2018 Aug;79(4):335-342
pubmed: 30009113
N Engl J Med. 2021 Apr 8;384(14):1335-1348
pubmed: 33826821
N Engl J Med. 1998 Nov 12;339(20):1426-33
pubmed: 9811917
Prog Neurol Surg. 2007;20:16-27
pubmed: 17317973
Neurosurg Rev. 2021 Dec;44(6):3527-3537
pubmed: 33839944
Neurosurgery. 2008 Oct;63(4):734-40; discussion 740
pubmed: 18981884
Radiother Oncol. 2009 Feb;90(2):208-12
pubmed: 19054586
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Neurosurgery. 2010 Nov;67(5):1335-40; discussion 1340
pubmed: 20871439
Radiat Oncol. 2006 Jul 20;1:22
pubmed: 16857055
J Neurooncol. 2014 Jan;116(1):187-93
pubmed: 24142200
Int J Part Ther. 2018 Spring;4(4):28-36
pubmed: 31773013
Radiother Oncol. 2018 Jul;128(1):26-36
pubmed: 29779919
Otol Neurotol. 2021 Dec 1;42(10):1560-1571
pubmed: 34538850
Neurosurgery. 2009 Feb;64(2):289-96; discussion 296
pubmed: 19057423
Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):35-44
pubmed: 12182972
Radiother Oncol. 2013 Feb;106(2):169-74
pubmed: 23219253
Surg Neurol. 2000 Dec;54(6):406-14
pubmed: 11240166
J Neurosurg. 2007 Nov;107(5):917-26
pubmed: 17977261
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e503-9
pubmed: 21665381
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1393-402
pubmed: 15817342
Neurosurgery. 2022 Oct 1;91(4):648-657
pubmed: 35973088
J Neurosurg. 2003 Oct;99(4):685-92
pubmed: 14567604
Radiother Oncol. 2015 Mar;114(3):378-83
pubmed: 25702864
Neurosurgery. 2022 May 1;90(5):506-514
pubmed: 35229827
Neurosurgery. 2002 Feb;50(2):270-3; discussion 273-5
pubmed: 11844261
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1265-78
pubmed: 11483338
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):419-26
pubmed: 19042095
J Neurosurg. 2007 Oct;107(4):733-9
pubmed: 17937216
Neurosurgery. 2003 Sep;53(3):577-86; discussion 586-8
pubmed: 12943574
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1381-7
pubmed: 11121637
Front Oncol. 2021 Nov 17;11:772831
pubmed: 34869012
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1390-6
pubmed: 12873685
Cochrane Database Syst Rev. 2014 Dec 16;(12):CD009897
pubmed: 25511415
J Radiosurg SBRT. 2017;5(1):5-24
pubmed: 29296459
Laryngoscope. 2009 Jun;119(6):1076-81
pubmed: 19399836
Int J Part Ther. 2018 Spring;4(4):37-46
pubmed: 31773014
Neurosurg Focus. 2012 Sep;33(3):E8
pubmed: 22937859

Auteurs

Antonio Santacroce (A)

European Radiosurgery Centre Munich, Munich, Germany.
Department of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
Department of Neurosurgery, St. Barbara-Klinik Hamm-Heessen, Hamm, 59073, Germany.

Mioara- Florentina Trandafirescu (MF)

University of Medicine and Pharmacy "Gr. T. Popa", Iasi, Germany.

Marc Levivier (M)

Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, CH-1011, Lausanne, Switzerland.
Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland.

David Peters (D)

Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, CH-1011, Lausanne, Switzerland.
Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland.

Christoph Fürweger (C)

European Radiosurgery Centre Munich, Munich, Germany.

Iuliana Toma-Dasu (I)

Oncology Pathology Department, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Medical Radiation Physics, Stockholm University, Stockholm, Sweden.

Mercy George (M)

ENT Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, CH-1011, Lausanne, Switzerland.
Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland.

Raphael Maire (R)

ENT Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Makoto Nakamura (M)

Department of Neurosurgery, Academic Hospital Köln-Merheim, Köln, 51058, Germany.
Department of Medicine, Faculty of Health, Witten/Herdecke University, Witten, 58455, Germany.

Mohamed Faouzi (M)

Division of Biostatistics, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Luis Schiappacasse (L)

Radiation Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Alexandru Dasu (A)

The Skandion Clinic and Uppsala University, Uppsala, Sweden.
Medical Radiation Sciences, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Constantin Tuleasca (C)

Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital (CHUV), Rue du Bugnon 44-46, BH-08, CH-1011, Lausanne, Switzerland. constantin.tuleasca@gmail.com.
Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), Lausanne, Switzerland. constantin.tuleasca@gmail.com.
Ecole Polytechnique Fédérale de Lausanne (EPFL, LTS-5), Lausanne, Switzerland. constantin.tuleasca@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH